SRNE   $0.299  -23.33% Market Closed

Sorrento Therapeutics Inc
Total Cash 80.64M
totalCashPerShare 0.148
EBITDA -341.59M
Total Debt 207.60M
quickRatio 0.345
currentRatio 0.405
Total Revenue 64.27M
debtToEquity
Revenue/Share 0.127
ROA -0.40815
ROE
grossProfits
freeCashflow -57.53M
operatingCashflow -234.63M
earningsGrowth
revenueGrowth 0.311
grossMargins -2.4501
ebitdaMargins 0.0
operatingMargins -5.10928
profitMargins 0.0
enterpriseValue 136.30M
forwardPE
floatShares 539.11M
sharesOutstanding 551.28M
sharesShort 64.56M
sharesShortPriorMonth 61.44M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.00%
Short Ratio help_outline 4.96%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue -0.377
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -548.00M
trailingEps -1.10%
forwardEps
enterpriseToEbitda -0.40
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2023
institutionsCount 9
lastUpdated Nov. 6, 2024, 5:25 p.m.